julien brillault MCU Université de Poitiers

Identifiants chercheurs

IdHAL :

julien-brillault

ORCID :

0000-0003-4207-5089

IdRef :

084547499

VIAF :

211183092

ISNI :

0000000432101017

Publications

Article dans une revue (23)

Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones Julien Brillault,Frederic Tewes Pharmaceutics, 2020, 12 (4), pp.E387. ⟨10.3390/pharmaceutics12040387⟩ Article dans une revue inserm-02558855v1
Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery Frederic Tewes,Julien Brillault,Nicolas Grégoire,Jean-Christophe Olivier,Isabelle Lamarcheet al. Pharmaceutics, 2020, 12 (6), pp.557. ⟨10.3390/pharmaceutics12060557⟩ Article dans une revue hal-02875013v1
Pulmonary Pharmacokinetics of Oseltamivir Carboxylate in Rats after Nebulization or Intravenous Administration of Its Prodrug, Oseltamivir Phosphate Romain Carrez,Julien Brillault,Nicolas Grégoire,Isabelle Lamarche,Julian Larocheet al. Antimicrobial Agents and Chemotherapy, 2019, 63 (6), ⟨10.1128/AAC.00074-19⟩ Article dans une revue hal-02477849v1
Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols Siti Nani Nurbaeti,Julien Brillault,Frédéric Tewes,Jean-Christophe Olivier European Journal of Pharmaceutical Sciences, 2019, 138, pp.105028. ⟨10.1016/j.ejps.2019.105028⟩ Article dans une revue hal-02477590v1
Active Mediated Transport of Chloramphenicol and Thiamphenicol in a Calu-3 Lung Epithelial Cell Model Siti Nurbaeti,Jean-Christophe Olivier,Christophe Adier,Sandrine Marchand,William Couetet al. Journal of Pharmaceutical Sciences, 2018, 107 (4), pp.1178-1184. ⟨10.1016/j.xphs.2017.11.021⟩ Article dans une revue hal-02481308v1
In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration. Julien Brillault,Frédéric Tewes,William Couet,Jean-Christophe Olivier European Journal of Pharmaceutical Sciences, 2017, 97, pp.92-98. ⟨10.1016/j.ejps.2016.11.011⟩ Article dans une revue inserm-01416565v1
Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam Sandrine Marchand,Nicolas Grégoire,Julien Brillault,Isabelle Lamarche,Patrice Gobinet al. Antimicrobial Agents and Chemotherapy, 2016, 60 (5), pp.3196-3198. ⟨10.1128/AAC.00165-16⟩ Article dans une revue hal-02470454v1
Ciprofloxacin-Loaded Inorganic–Organic Composite Microparticles To Treat Bacterial Lung Infection Frederic Tewes,Julien Brillault,Barbara Lamy,Peter O 'Connell,Jean-Christophe Olivieret al. Molecular Pharmaceutics, 2015, 13 ((1)), pp.100-112. ⟨10.1021/acs.molpharmaceut.5b00543⟩ Article dans une revue inserm-01373710v1
Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin Sandrine Marchand,Nicolas Grégoire,Julien Brillault,Isabelle Lamarche,Patrice Gobinet al. Antimicrobial Agents and Chemotherapy, 2015, 59 (10), pp.6646-6647. ⟨10.1128/AAC.01647-15⟩ Article dans une revue hal-02477997v1
Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 1. Ciprofloxacin, Moxifloxacin, and Grepafloxacin Aline Vidal Lacerda Gontijo,Julien Brillault,Nicolas Grégoire,Isabelle Lamarche,Patrice Gobinet al. Antimicrobial Agents and Chemotherapy, 2014, 58 (7), pp.3942-3949. ⟨10.1128/AAC.02818-14⟩ Article dans une revue hal-02477506v1
Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats S. Marchand,P. Gobin,J. Brillault,S. Baptista,C. Adieret al. Antimicrobial Agents and Chemotherapy, 2010, 54 (9), pp.3702-3707. ⟨10.1128/AAC.00411-10⟩ Article dans une revue hal-02472561v1
Relative Contributions of Active Mediated Transport and Passive Diffusion of Fluoroquinolones with Various Lipophilicities in a Calu-3 Lung Epithelial Cell Model J. Brillault,W. de Castro,W. Couet Antimicrobial Agents and Chemotherapy, 2009, 54 (1), pp.543-545. ⟨10.1128/AAC.00733-09⟩ Article dans une revue hal-02466429v1
P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3 Lung Epithelial Cell Model Julien Brillault,Whocely Victor de Castro,Thomas Harnois,Alain Kitzis,Jean Christophe Olivieret al. Antimicrobial Agents and Chemotherapy, 2009, 53 (4), pp.1457-1462. ⟨10.1128/AAC.01253-08⟩ Article dans une revue hal-00456585v1
Formulation of rifampicin–cyclodextrin complexes for lung nebulization Frederic Tewes,Julien Brillault,William Couet,Jean-Christophe Olivier Journal of Controlled Release, 2008, 129, pp.93 - 99. ⟨10.1016/j.jconrel.2008.04.007⟩ Article dans une revue inserm-01102812v1
VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1 Samuel Valable,Joan Montaner,Anita Bellail,Vincent Berezowski,Julien Brillaultet al. Journal of Cerebral Blood Flow and Metabolism, 2005, p. 1-14 Article dans une revue hal-00542804v1
Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process Karim Benchenane,Vincent Berezowski,Monica Fernandez-Monreal,Julien Brillault,Samuel Valableet al. Stroke, 2005, p. 1059-1064 Article dans une revue hal-00542010v1
Moderate-to-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na + -K + -Cl − cotransporter Shahin Foroutan,Julien Brillault,Biff Forbush,Martha O’donnell American Journal of Physiology - Cell Physiology, 2005, 289 (6), pp.C1492-C1501. ⟨10.1152/ajpcell.00257.2005⟩ Article dans une revue hal-02490493v1
Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor–related protein-mediated transcytosis Karim Benchenane,Vincent Berezowski,Carine Ali,Monica Fernandez-Monreal,José P. Lopez-Atalayaet al. Circulation, 2005, p. 2241-2249 Article dans une revue hal-00542121v1
Neuroprotective properties of tianeptine: interactions with cytokines F. Plaisant,M.-A. Dommergues,Michael Spedding,Roméo Cecchelli,J. Brillaultet al. Neuropharmacology, 2003, 44, p. 801-809 Article dans une revue hal-00527163v1
Lessons from CADASIL Marie-Magdeleine Ruchoux,Peggy Brulin,Julien Brillault,Marie-Pierre Dehouck,Roméo Cecchelliet al. Annals of the New York Academy of Sciences, 2002, 977, p. 224-231. ⟨10.1111/j.1749-6632.2002.tb04819.x⟩ Article dans une revue istex hal-00537342v1
Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia Julien Brillault,Vincent Berezowski,Roméo Cecchelli,Marie-Pierre Dehouck Journal of Neurochemistry, 2002, 83, p. 807-817 Article dans une revue hal-00525298v1
Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models Stefan Lundquist,Mila Renftel,Julien Brillault,Laurence Fenart,Roméo Cecchelliet al. Pharmaceutical Research, 2002, 19 (7), p. 976-981 Article dans une revue hal-00537269v1
Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models Stefan Lundquist,M. Rentfel,Julien Brillault,Laurence Fenart,Romeo Cecchelliet al. Pharmacological Research, 2002, ⟨10.1023/a:1016462205267⟩ Article dans une revue istex hal-02490540v1

Brevet (1)

Inhalable microparticles loaded with a fluoroquinolone/metal cation complex for the treatment of respiratory diseases Frédéric Tewes,Julien Brillault,Hugh D.C. Smyth France, Patent n° : WO2018104759A1. 2018 Brevet hal-02485017v1